United States · Platforms & data · MarketBeat

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Published by MarketBeat · United States 1 h ago

Dr. Reddy's Laboratories Ltd (NYSE:RDY - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are presently covering the firm, Marketbeat…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

TheStreet

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

Stocktwits

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Share

Also worth reading

Down 17%, Is Meta a Buy on the Dip?

Johnson & Johnson reports response rate for head, neck cancer treatment

Goldman lists 3 factors that support long commodities positions

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

TeraWulf CEO Paul Prager Turns Elon Musk’s ‘Stranded Compute’ Warning Into A Buying Pitch